CN104815115A - Traditional Chinese medicine composition for treating migraine - Google Patents
Traditional Chinese medicine composition for treating migraine Download PDFInfo
- Publication number
- CN104815115A CN104815115A CN201510262955.9A CN201510262955A CN104815115A CN 104815115 A CN104815115 A CN 104815115A CN 201510262955 A CN201510262955 A CN 201510262955A CN 104815115 A CN104815115 A CN 104815115A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- radix
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition. The invention aims to provide a traditional Chinese medicine composition for treating the migraine based on the theory of traditional Chinese medicine through the dialectic analysis of the migraine symptom. The traditional Chinese medicine composition is prepared from the following raw herbal materials in parts by weight: 3-9 parts of radix bupleuri, 6-15 parts of Chinese herbaceous peony, 10-20 parts of Scutellaria baicalensis, 10-20 parts of Coptis chinensis, 6-15 parts of Pinellia ternate, 3-9 parts of fructus aurantii, 3-9 parts of Mangnolia officinalis, 3-9 parts of Chinese rhubarb, 6-15 parts of keel, 6-15 parts of oyster, 3-9 parts of liquorice, 3-9 parts of areca-nut, 6-15 parts of honeysuckle, 6-15 parts of cyrtophyllum, 3-9 parts of selfheal and 3-9 parts of wrinkled giant hyssop. The compatibility of common medicines is reasonable and the dosage is determined carefully so that the traditional Chinese medicine composition has a satisfactory treating effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, particularly relate to one and treat migrainous Chinese medicine preparation.
Background technology
Migraine is clinical modal primary headache type; clinical with ictal middle severe, sample of beating headache for main manifestations; headache mostly is square toes side in ear; general lasting 4 ~ 72 hours; can with diseases such as Nausea and vomiting; light, Sound stimulat or daily routines all can increase the weight of headache, and quiet environment, rest can alleviate headache.Modern medicine is thought, migraine is a kind of common chronic forms vascular illness, and a lot of disease is in child and adolescence, and the young and middle-aged phase reaches onset peak, and women is common, and men and women's Proportion of patients is about 1: 2 ~ 3, and in crowd, prevalence is 5% ~ 10%, often has genetic background.Current migrainous Therapeutic Method can be divided into medicine and non-drug therapy two kinds, Drug therapy can be divided into two kinds again, whether first migraine all takes to reduce seizure frequency and the prophylactic treatment of the degree that eases the pain every day, its two treatment when being migraines, as aspirin, paracetamol, non-corticosteroid anti-inflammatory agent etc., it is long all to there is administration time in above two kinds of Therapeutic Method, side effect is large, dependent problem is produced after patient's long-term taking, treatment by Chinese herbs be can yet be regarded as a kind of stable curative effect, the method that side effect is little.
Summary of the invention
The object of the invention is to take theory of Chinese medical science as foundation, by the dialectical Analyses of migraine one disease and then provide a kind of Chinese medicine composition for the treatment of this disease.
For realizing above-mentioned technical purpose, the technical solution adopted in the present invention is: one treats migrainous Chinese medicine composition, it is characterized in that, this Chinese medicine composition adopts the material medicine of following weight proportion to combine: Radix Bupleuri 3-9 part, Radix Paeoniae 6-15 part, Radix Scutellariae 10-20 part, Rhizoma Coptidis 10-20 part, Rhizoma Pinelliae 6-15 part, Fructus Aurantii 3-9 part, Cortex Magnoliae Officinalis 3-9 part, Radix Et Rhizoma Rhei 3-9 part, Os Draconis 6-15 part, Concha Ostreae 6-15 part, Radix Glycyrrhizae 3-9 part, Semen Arecae 3-9 part, Flos Lonicerae 6-15 part, Folium Isatidis 6-15 part, Spica Prunellae 3-9 part, Herba Pogostemonis 3-9 part.
The optimum weight proportioning of above-mentioned raw materials medicine is: Radix Bupleuri 6 parts, Radix Paeoniae 10 parts, Radix Scutellariae 15 parts, Rhizoma Coptidis 15 parts, the Rhizoma Pinelliae 9 parts, Fructus Aurantii 6 parts, Cortex Magnoliae Officinalis 6 parts, Radix Et Rhizoma Rhei 6 parts, Os Draconis 9 parts, Concha Ostreae 9 parts, 6 parts, Radix Glycyrrhizae, Semen Arecae 6 parts, Flos Lonicerae 9 parts, Folium Isatidis 9 parts, Spica Prunellae 6 parts, Herba Pogostemonis 6 parts.
The instructions of taking of this Chinese medicine composition is: after being mixed in grams by the material medicine of above-mentioned weight proportion, conveniently the method for fried Chinese medicine gets its medicine juice 300-500ml, and every day one is secondary, and a point morning and evening drinks for twice.
Prescription analysis: the traditional Chinese medical science is thought " general rule not bitterly, pain then obstructed ", and migraine is mainly in square toes side in ear, and this position belongs to the Gallbladder Channel of Foot-Shaoyang institute network part, in addition migraine institute is with having substantial connection with the known migraine of the diseases such as Nausea and vomiting and gallbladder.Fire is to change mutually from the few sun of hands for foot-shaoyang gallbladder, and following behavior is suitable, and now gallbladder does not fall then in the few positive first wood of foot, and two fire are upper scorching mutually, block the Lu Bixian headache of the Gallbladder Channel of Foot-Shaoyang, and falling of the few positive first wood of foot is to turn under penta soil, penta soil and stomach, the bright existing stomach of the diseases such as Nausea and vomiting does not cause first wood superinverse by appearance.So in Chinese medicine composition provided by the present invention, get Radix Scutellariae, Rhizoma Coptidis, Spica Prunellae let out its gallbladder fire, Fructus Aurantii, Cortex Magnoliae Officinalis, Radix Et Rhizoma Rhei, the Rhizoma Pinelliae, Semen Arecae swing wherein burnt congested, and the turbid descending therapeutic method to keep the adverse QI flowing downwards, its phase fire falls in Os Draconis, Concha Ostreae.Middle Jiao does not fall, and edema with the liver involved is raw not hot and suffocating to change, and flaming up of the ministerial fire is its heart liquid bright then, therefore in Chinese medicine composition, get Radix Bupleuri soothing the liver, the cool liver lung heat clearing of Flos Lonicerae, Folium Isatidis fresh breeze, and Radix Paeoniae supports battalion.And middle Jiao does not fall, must Nausea and vomiting be showed, get Herba Pogostemonis stopping nausea and vomiting by lowering the adverse flow of QI.Above-mentioned all medicines share, penta lower turn of soil, and mutually two fire are with clearly for gallbladder, then first wood is descending, mutually fiery dive, and wind is quiet woodenly gives birth to, and the Gallbladder Channel of Foot-Shaoyang QI and blood is unobstructed, and migraine one disease is explained by oneself.Although this Chinese medicine composition is common drug on choice of drug, by disease dialectical Analyses accurately, conventional medicine is carried out reasonable compatibility, consideration consumption, it can obtain gratifying therapeutic effect.
Detailed description of the invention
Below in conjunction with embodiment, Chinese medicine composition provided by the present invention is described further.
Embodiment 1
One treats migrainous Chinese medicine composition, it is characterized in that, this Chinese medicine composition adopts the material medicine of following weight proportion to combine: Radix Bupleuri 6g, Radix Paeoniae 10g, Radix Scutellariae 15g, Rhizoma Coptidis 15g, Rhizoma Pinelliae 9g, Fructus Aurantii 6g, Cortex Magnoliae Officinalis 6g, Radix Et Rhizoma Rhei 6g, Os Draconis 9g, Concha Ostreae 9g, Radix Glycyrrhizae 6g, Semen Arecae 6g, Flos Lonicerae 9g, Folium Isatidis 9g, Spica Prunellae 6g, Herba Pogostemonis 6g.
The Chinese medicine composition provided in the present embodiment is observed by extracting 96 routine Clinical practice in the patient that accepts for medical treatment between 2012 to 2014 years: selected patient patient is divided into two groups at random: treatment group 48 example, man 20 example, female 28 example, 37.5 years old mean age.Matched group 48 falls, man 24 example, female 24 example, 36.4 years old mean age.Two groups of ages, sexes have comparability (P>0.05).
Diagnostic criteria:
With reference to the diagnostic criteria of " internal medicine common disease conventional treatment " medium vessels nervous headache; (1) headache recurrent exerbation, the course of disease more than 3 months.(2) painful area is many at side or bilateral, or entirely has a headache, and characteristic of pain mostly is distending pain, jumping pain, twinge, dusk bitterly.Dull pain or explosion sample pain, the persistent period is several minutes, a few hours, a few days, several weeks, can spontaneous remission.(3) acute or subacute morbidity, start-stop is variable.(4) morbidity can have inducement, and premorbid often has premonitory symptom.(5) TCD,transcranial Doppler display cerebral vasospasm or expansion.(6) nervous system and other inspections, get rid of the headache caused by Other diseases.
Therapeutic scheme
Treatment group: take the Chinese medicine composition that the present embodiment provides.
Matched group: adopt divalproex sodium 5mg+ ibuprofen 5m, every day 1 time is oral, oryzanol lOmg, and every day 3 times is oral.
At treatments period, all avoid and drink for two groups, tired, keep in high spirits, take a good rest, avoid tightly swollen and direct stimulation, two groups equal 7 days is a course for the treatment of.
Criterion of therapeutical effect is cured:
Headache syndromes disappears completely, follows up a case by regular visits to without recurrence through 1 year.Effective: headache syndromes disappears substantially
Lose or obviously alleviate, other transference cures.Effective: headache syndromes alleviates in various degree, attack times obviously reduces, decreased duration, and other symptoms take a turn for the better.Invalid: before and after treatment, headache syndromes is without change.
Therapeutic outcome judges curative effect after two courses for the treatment of.
Treatment group 48 example, wherein cures 23 examples (47.9%), effective 12 examples (25%), effective 11 examples (22.9%), invalid 2 examples (4.2%), total effective rate 95.83%; Matched group 48 example, wherein cures 15 examples (31.25%), effective 14 examples (29.16%), effective 8 examples (16.67%), invalid 11 examples (22.9%), total effective rate 77.08%.
Two groups of comparitive study, treatment group curative effect is better than matched group.
Model case
Patient, Lee, female, 33 years old, the regular panic attacks of both sides head, persistent period 0.5-2 days, during outbreak, took antalgica and slightly alleviates, but can not thoroughly eliminate, and medical history 3 years is repeatedly sought medical advice and must do not eradicated.Time medical, except cephalic pain, the symptom such as having feed vomiting concurrently, feel sick, its cun of pulse-taking, to close floating and large pulse strong, and red tongue, yellow fur, diagnoses its migraine caused by flaming up of the ministerial fire.
Take the secondary rear pain of Chinese medicine composition two provided by the present invention thoroughly to disappear, continue to take this Chinese medicine composition 5 pair and consolidated, follow up a case by regular visits to and do not recur for 1 year.
Embodiment 2
One treats migrainous Chinese medicine composition, it is characterized in that, this Chinese medicine composition adopts the material medicine of following weight proportion to combine: Radix Bupleuri 3 parts, Radix Paeoniae 15 parts, Radix Scutellariae 10 parts, Rhizoma Coptidis 20 parts, the Rhizoma Pinelliae 6 parts, Fructus Aurantii 9 parts, Cortex Magnoliae Officinalis 3 parts, Radix Et Rhizoma Rhei 9 parts, Os Draconis 6 parts, Concha Ostreae 15 parts, 3 parts, Radix Glycyrrhizae, Semen Arecae 9 parts, Flos Lonicerae 6 parts, Folium Isatidis 15 parts, Spica Prunellae 3 parts, Herba Pogostemonis 9 parts.
Embodiment 3
One treats migrainous Chinese medicine composition, it is characterized in that, this Chinese medicine composition adopts the material medicine of following weight proportion to combine: Radix Bupleuri 9 parts, Radix Paeoniae 6 parts, Radix Scutellariae 20 parts, Rhizoma Coptidis 10 parts, the Rhizoma Pinelliae 15 parts, Fructus Aurantii 3 parts, Cortex Magnoliae Officinalis 9 parts, Radix Et Rhizoma Rhei 3 parts, Os Draconis 15 parts, Concha Ostreae 6 parts, 9 parts, Radix Glycyrrhizae, Semen Arecae 3 parts, Flos Lonicerae 15 parts, Folium Isatidis 6 parts, Spica Prunellae 9 parts, Herba Pogostemonis 3 parts.
Claims (2)
1. the migrainous Chinese medicine composition for the treatment of, it is characterized in that, this Chinese medicine composition adopts the material medicine of following weight proportion to combine: Radix Bupleuri 3-9 part, Radix Paeoniae 6-15 part, Radix Scutellariae 10-20 part, Rhizoma Coptidis 10-20 part, Rhizoma Pinelliae 6-15 part, Fructus Aurantii 3-9 part, Cortex Magnoliae Officinalis 3-9 part, Radix Et Rhizoma Rhei 3-9 part, Os Draconis 6-15 part, Concha Ostreae 6-15 part, Radix Glycyrrhizae 3-9 part, Semen Arecae 3-9 part, Flos Lonicerae 6-15 part, Folium Isatidis 6-15 part, Spica Prunellae 3-9 part, Herba Pogostemonis 3-9 part.
2. one according to claim 1 treats migrainous Chinese medicine composition, it is characterized in that, the optimum weight proportioning of described material medicine is: Radix Bupleuri 6 parts, Radix Paeoniae 10 parts, Radix Scutellariae 15 parts, Rhizoma Coptidis 15 parts, the Rhizoma Pinelliae 9 parts, Fructus Aurantii 6 parts, Cortex Magnoliae Officinalis 6 parts, Radix Et Rhizoma Rhei 6 parts, Os Draconis 9 parts, Concha Ostreae 9 parts, 6 parts, Radix Glycyrrhizae, Semen Arecae 6 parts, Flos Lonicerae 9 parts, Folium Isatidis 9 parts, Spica Prunellae 6 parts, Herba Pogostemonis 6 parts.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510262955.9A CN104815115A (en) | 2015-05-22 | 2015-05-22 | Traditional Chinese medicine composition for treating migraine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510262955.9A CN104815115A (en) | 2015-05-22 | 2015-05-22 | Traditional Chinese medicine composition for treating migraine |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104815115A true CN104815115A (en) | 2015-08-05 |
Family
ID=53725758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510262955.9A Pending CN104815115A (en) | 2015-05-22 | 2015-05-22 | Traditional Chinese medicine composition for treating migraine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104815115A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105106905A (en) * | 2015-09-23 | 2015-12-02 | 黄名珠 | Traditional Chinese medicine prescription for treating headache |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103239582A (en) * | 2013-06-03 | 2013-08-14 | 赵德喜 | Chinese medicinal preparation for treating migraine |
-
2015
- 2015-05-22 CN CN201510262955.9A patent/CN104815115A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103239582A (en) * | 2013-06-03 | 2013-08-14 | 赵德喜 | Chinese medicinal preparation for treating migraine |
Non-Patent Citations (7)
Title |
---|
俞小平等主编: "《中国古方新用》", 30 June 1999, 科学技术文献出版社 * |
冷方南主编: "《中医内科临床治疗学》", 31 May 1987, 上海科学技术出版社/河南科学技术出版社 * |
张静华等: "大柴胡汤加减治疗内科杂证", 《实用中医内科杂志》 * |
杜青等: "偏头痛中医药治疗进展", 《吉林中医药》 * |
王发强等: "大柴胡汤加味治疗血管性头痛", 《长治医学院学报》 * |
陈纪藩主编: "《金匮要略》", 31 October 2012, 人民卫生出版社 * |
高学敏等主编: "《临床中药学》", 31 January 2006, 河北科学技术出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105106905A (en) * | 2015-09-23 | 2015-12-02 | 黄名珠 | Traditional Chinese medicine prescription for treating headache |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103705603B (en) | Traditional Chinese medicine for treating acne | |
CN102293947A (en) | Traditional Chinese medicine for treating hypertension | |
CN102091270B (en) | Medicament for treating neurodermatitis | |
CN104474471A (en) | Traditional Chinese medicine composition for treating thyroid | |
CN103721190B (en) | A kind of cyst type acne mixture | |
CN103432559B (en) | Traditional Chinese medicine composition for treating spanomenorrhea and dysmenorrhea caused by blood stasis and preparation method and application thereof | |
CN102512617B (en) | Chinese herbal preparation for treating psoriasis | |
CN100998722B (en) | Oral traditional Chinese medicine for treating delayed menstrual ciycle menalgia | |
CN102302733B (en) | Oral Chinese medicinal composition for treating ovarian cyst | |
CN102068639B (en) | Externally traditional Chinese medicine for treating pustulosis | |
CN104784346A (en) | Pruritus treating traditional Chinese medicine lotion preparation method | |
CN104645078A (en) | Traditional Chinese medicine composition for treating migraine | |
CN104815115A (en) | Traditional Chinese medicine composition for treating migraine | |
CN103110756B (en) | Traditional Chinese medicine composition for treating renal hematuria | |
CN102283967A (en) | Chinese medicinal composition for treating pain in lateral lower abdomen | |
CN101579507B (en) | Medicine for treating gall stones and preparation method thereof | |
CN100998804A (en) | Oral Chinese medicine for treating damp-heat type shingles | |
CN104888178A (en) | Infantile diarrhea treatment traditional Chinese medicine | |
CN103705629B (en) | A kind of Chinese medicine composition for the treatment of pruritus | |
CN103800561A (en) | Traditional Chinese medicine for treating renal hematuria | |
CN103494900A (en) | Traditional Chinese medicine for treating stiff neck | |
CN104013836A (en) | Traditional Chinese medicine composition for treating sequela of cerebral apoplexy | |
CN104055959A (en) | Traditional Chinese medicine lotion and nursing method for treating gastrointestinal dampness-heat type seborrhoeic dermatitis | |
CN104645213A (en) | External traditional Chinese medicine for treating warts | |
CN109316594B (en) | Decoction of Ershu dendrobe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
EXSB | Decision made by sipo to initiate substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150805 |
|
WD01 | Invention patent application deemed withdrawn after publication |